BPC-157 restores blood flow
Wild B, Hnnemeyer K, Sauer H, Schellberg D, Mller-Stich BP, Knigsrainer A, et al
The White House says that "for too many Americans, these critical treatments are too expensive and therefore out of reach," and, "without insurance coverage, these drugs can cost someone as much as $1,000 a month." GLP-1 (glucagon-like peptide) receptor agonists are commonly prescribed to patients with type 2 diabetes (to stabilize blood glucose levels) or obesity (to assist with weight loss)
Cost comparison: Monthly protocols vary widely
The severity was uniformly mild, consisting of temporary redness, minor swelling, or brief tenderness lasting a few hours
For the full SLU-PP-332 dosing breakdown, see the SLU-PP-332 Dosing Guide